0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query gbi research endpoints clinical trials orphan diseases highest number terminated trials focused.Your search for "" gave back 1532719 results.
Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2018 Summary According to the recently published report 'Glucagon Like Peptide 2...
Catalog:
Global Markets Direct
August 2018
Price: USD 3,500.00
Collagenase 3 - Pipeline Review, H2 2019 Summary According to the recently published report 'Collagenase 3 - Pipeline Review, H2 2019';...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players Summary GBI Research’s latest report,...
Catalog:
CBR Pharma Insights
October 2018
Price: USD 2,995.00
Collagenase 3 - Pipeline Review, H1 2020 Summary Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) pipeline Target constitutes close...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook Summary GBI Research’s latest report, "Gene Therapies: A...
Catalog:
CBR Pharma Insights
September 2015
Price: USD 2,995.00
A Disintegrin And Metalloproteinase With Thrombospondin Motifs 5 - Pipeline Review, H1 2020 Summary A Disintegrin And Metalloproteinase With...
Catalog:
Global Markets Direct
February 2020
Price: USD 3,500.00
Acromegaly - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acromegaly -...
Catalog:
Global Markets Direct
September 2018
Price: USD 2,000.00
Gastric Inhibitory Polypeptide Receptor - Drugs In Development, 2021 Summary Gastric Inhibitory Polypeptide Receptor (Glucose Dependent...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
Collagenase 3 - Pipeline Review, H2 2020 Summary Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) pipeline Target constitutes close...
Catalog:
Global Markets Direct
October 2020
Price: USD 3,500.00
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Drugs In Development, 2021 Summary Alpha L-Iduronidase (IDUA or EC 3.2.1.76) pipeline Target constitutes...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Transthyretin (ATTR or Prealbumin or TBPA or TTR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
September 2022
Price: USD 3,500.00
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H1 2018 Summary According to the recently published report 'Alpha L-Iduronidase (...
Catalog:
Global Markets Direct
June 2018
Price: USD 3,500.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, “Innovation...
CBR Pharma Insights
May 2017
Price: USD 2,995.00
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Pipeline Review, H2 2018 Summary Transthyretin (ATTR or Prealbumin or TBPA or TTR) -...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
The global Rare Disease Clinical Trial market is projected to reach US$ 57 million in 2029, increasing from US$ 45 million in 2022, with the CAGR of...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
